Osteonecrosis of the Jaw associated with the Use of Bisphosphonates
Matheus Coelho Bandéca, Rafael Soares Diniz, Francisco José Lima Maciel, Andrezza De Almeida Bastos Maciel, Marcio Antônio Rodrigues Araújo, Ana Paula Fernandes Lamha, Erika Martins Pereira
Citation Information :
Bandéca MC, Diniz RS, Maciel FJ, De Almeida Bastos Maciel A, Araújo MA, Lamha AP, Pereira EM. Osteonecrosis of the Jaw associated with the Use of Bisphosphonates. World J Dent 2015; 6 (2):116-122.
Copyright © 2015; The Author(s).
How to cite this article
Diniz RS, Maciel FJL, De Almeida Bastos Maciel A, Araújo MAR, Lamha APF, Bandeca MC, Pereira EM. Osteonecrosis of the Jaw associated with the Use of Bisphosphonates. World J Dent 2015;6(2):116-122.
Bisphosphonate osteonecrosis of the jaw: a historical and contemporary review. Surgeon 2012 Feb;10(1):36-42.
Intravenous bisphosphonates and osteonecrosis. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2004;98:259-260.
Jaw osteonecrosis related to bisphosphonate therapy a severe secondary disorder. Bone 2007;40:828-834.
Osteonecrosis of the jaws associated with the use of bisphosphonates: a review of 63 cases. J Maxillofac Surg 2004;62:527-534.
Bisphosphonates-related osteonecrosis of the jaws: a concise review of the literature and a report of a single-centre experience with 151 patients. J Oral Pathol Med 2012 Mar;41(3):214-221.
Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of jaws: a growing epidemic. J Oral Maxillofac Surg 2003;61:1115-1117.
Osteonecrosis of the jaws in patients treated with intravenous bisphosphonates (BRONJ): a concise update. Oral Oncol 2009;45:551-554.
Position paper on bisphosphonate: related osteonecrosis of the jaws. J Oral Maxillofac Surg 2007;65(3):369-374.
Celluar and molecular mechanisms of action of bisphosphonates. Cancer 2000;88(12):2961-2978.
Bisphosphonates and osteonecrosis: potential treatment or serious complication. Orthop Clin N AM 2009:223-224.
Osteonecrosis of the jaws in patients treated with bisphosphonates. J Clin Exp Dent 2012;4(1):e60-65.
Bisphosphonate related osteonecrosis of the jaws. J Ayub Med Coll Abbottabad 2010; 22(3):214-217.
Managing the care of patients with bisphosphonateassociated osteonecrosis: an American Academy of Oral Medicine position paper. J Am Dent Assoc 2006;137(1):26.
Oral bisphosphonate-induced osteonecrosis: risk factors, prediction of risk using serum CTX testing, prevention, and treatment. J Oral Maxillofac Surg 2007;65(12):2397-2410.
The new bisphosphonate, Zometa (zoledronic acid), decreases skeletal complications in both osteolytic and osteoblastic lesions: a comparison to pamidronate. Cancer Invest 2002;20(Suppl 2):45-54.
Osteonecrosis of the jaw induced by clodronate, an alkylbiphosphonate: case report and literature review. Eur J Clin Pharmacol 2010 Jun;66(6):547-554.
Bisphosphonate-associated osteonecrosis of the jaw, with healing after teriparatide: a review of the literature and a case report. Spec Care Dentist 2010;30(2):77-82.
Effect of alendronate on endosseous implant integration: a in vivo study. J Oral Maxillofac Surg 2006;64:1005-1009.
Bisphosphonate-associated osteonecrosis of the jaw in breast cancer patients: recommendations for prevention and treatment. Breast 2009 Aug;18(4):213-217.
Paratireóides e doenças ósseas metabólicas. In Wajchenberg BL. Tratado de endocrinologia clínica. Sào Paulo: Roca; 1992. p. 845-907.
Bisphosphonate and nonbisphosphonate-associated osteonecrosis of the jaw: a review. J Am Dent Assoc 2009 Jul;140(7):864-875.
Bisphosphonate—related osteonecrosis of the jaw: diagnosis, prevention, and management. Annu Rev Med 2009;60:85-96.
Bisphosphonate —induced exposed bone (osteonecrosis/osteopetrosis) of the jaws: risk factors, recognition, prevention, and treatment. J Maxillofac Surg 2005;63(11):1567-1575.
American Association of Oral and Maxillo facial Surgions position paper on bisphosphonate: related osteonecrosis of the jaws 2009 update. J Oral Maxillofac Surg 2009;67(5):2-12.
Lengthening the human mandible by gradual distraction. Plast Reconstr Surg 1992;89(1):1-8.
Effects of alendronate on the removal toque of implants in rats with induced osteoporosis. J Oral Maxillofac Implants 2003;18:218-223.
Bisphosphonate-related osteonecrosis: genetic and acquired risk factors. Oral Dis 2009;15:382-387.